Traditional epidemiological studies have identified numerous potential risk factors, but observational studies have struggled to establish causal links due to confounding factors and reverse causation ...

Transgene has completed patient randomisation in the phase 2 part of its phase 1/2 clinical trial evaluating TG4050, an individualised neoantigen therapeutic vaccine being developed for the adjuvant ...

Phase 3 Mascot study reaches key milestone for potential first-in-class therapy Lundbeck has announced that the final patient has been randomised ahead of schedule in its global phase 3 Mascot trial, ...

A reliance on chance when it comes to music making can, arguably, clash with the image we create for ourselves as musicians. Whether we’re talking about writing, sound design or mixing, musicians tend ...